BCCM
TEVA icon

Bridge Creek Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bridge Creek Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-30,425
Closed -$281K – 92
2019
Q2 		$281K Buy
30,425
+2,600
+9% +$31.4K 0.14% 83
2019
Q1 		$436K Sell
27,825
-675
-2% -$11.9K 0.22% 72
2018
Q4 		$439K Sell
28,500
-100
-0.3% -$2.05K 0.25% 70
2018
Q3 		$616K Sell
28,600
-107
-0.4% -$2.48K 0.31% 64
2018
Q2 		$698K Sell
28,707
-245
-0.8% -$5K 0.37% 63
2018
Q1 		$495K Buy
28,952
+125
+0.4% +$2.44K 0.26% 69
2017
Q4 		$546K Sell
28,827
-10,870
-27% -$164K 0.27% 65
2017
Q3 		$699K Buy
39,697
+8,255
+26% +$186K 0.37% 63
2017
Q2 		$1.04M Sell
31,442
-19
-0.1% -$588 0.57% 58
2017
Q1 		$1.01M Buy
31,461
+5,750
+22% +$196K 0.56% 58
2016
Q4 		$932K Buy
25,711
+442
+2% +$17.6K 0.53% 58
2016
Q3 		$1.16M Buy
25,269
+4,665
+23% +$243K 0.67% 55
2016
Q2 		$1.03M Buy
20,604
+1,765
+9% +$94K 0.61% 56
2016
Q1 		$1.01M Hold
18,839
– – 0.58% 58
2015
Q4 		$1.24M Buy
+18,839
New +$1.16M 0.75% 54

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Bridge Creek Capital Management's TEVA Position: Q3 2019 in Review

Bridge Creek Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 30,425 shares — an estimated $281K sold.

Bridge Creek Capital Management first reported a position in TEVA in Q4 2015 and held it in 15 quarters. The position peaked at $1.24M in Q4 2015. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Bridge Creek Capital Management reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Bridge Creek Capital Management sold 30,425 Teva Pharmaceuticals shares in Q3 2019, an estimated $281K.
  • Bridge Creek Capital Management first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 15 quarters.
  • Bridge Creek Capital Management's Teva Pharmaceuticals position peaked at $1.24M in Q4 2015.
  • 427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Bridge Creek Capital Management's 13F filing for Q3 2019, filed 10 Oct 2019.